EFFECTS OF IV GLUCOSE AND ORAL MEDIUM-CHAIN TRIGLYCERIDE IN PATIENTS WITH VLCAD DEFICIENCY
Neurology Ørngreen et al.
69: 313
Data Supplement
One table; Word document.
Files in this Data Supplement:
E1
-
E-Table 1: Plasma metabolites, hormones and pulmonary findings in two patients with VLCAD deficiency at rest and during 60 min. cycle exercise at 50% of maximal oxygen uptake with IV glucose, IV placebo, oral MCT or placebo (mean ± SE); Word document.
